The Best Way To Play The CBD Market

 

June 6, 2019 -- InvestorsHub NewsWire -- via Goldman Small Cap Research -- 
Rob@GoldmanResearch.com



CBD-infused product sales have been strong this year and demand is high. Which company will come out on top in terms of sales growth and stock price appreciation? Puration Inc. (OTC – PURA – Speculative Buy). Here’s why.


FAST FACTS

  • Demand Is So Strong, PURA Opened a 2nd  Plant. PURA has been contending with an enviable problem; demand is high and growing but production has not kept up. The new capacity utilization should essentially double its previous production capability.
  • Despite PURA’s light trading volume of late, a series of company initiatives and industry events serve as catalysts to drive PURA’s volume higher and the shares back to its 52-week high of $0.25. Depending upon the timing and magnitude of the aforementioned events, we believe that these shares have the potential to reach the $0.35 mark. 
  • PURA Is the Best Positioned CBD-infused Provider. The bulk of PURA sales are in the South/Southwest regions. This is key because some southern states are designing their own regulatory guidelines to foster sales, potentially bypassing the FDA in case they drag their feet. 
  • The NOUV Dividend Transaction Is a Sweetener. In our view, upon completion, the NOUV dividend adds meaningful value to PURA’s stock. Based on the current market cap, we believe PURA’s current share price does not reflect this hidden value. 
  • Sales Estimates Likely Too Low; M&A on the Way? Given the big increase in production capacity, sales projections for 2019 could be low and sales growth next year could be further bolstered by M&A—which would leverage PURA’s early mover infrastructure, sales, and its current formulation advantages. A critical mass of sales from M&A could in turn make PURA a future buyout candidate,

What does this all mean?
These series of company initiatives and industry events should serve as catalysts to drive PURA’s volume higher and the shares back to its 52-week high. Depending upon the timing and magnitude of the aforementioned events, we believe that these shares have the potential to break well above it.

See Goldman Small Cap Research’s full report on PURA.

Goldman Small Cap Research has also recently published research reports on Zenovtek  (ZVTK), and Nouveau (NOUV).

Disclaimer

Please visit our website www.GoldmanResearch.com and the associated publications for all disclaimers and compensation disclosures related to all stocks referred to or mentioned in this email that are profiled in The Goldman Guide, any Opportunity Research (sponsored) reports, updates, alerts, podcasts, or in our Market Monitorblogs, or under the Marble Arch Research , Inc. banner.

Separate from the factual content of our reports and articles about the Company, we may from time to time include our own opinions about the Company, its business, markets and opportunities. Any opinions we may offer about the Company are solely our own, and are made in reliance upon our rights under the First Amendment to the U.S. Constitution, and are provided solely for the general opinionated discussion of our readers. Our opinions should not be considered to be complete, precise, accurate, or current investment advice. Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results.

A Goldman Small Cap Research report, update, newsletter, article, podcast, alert, or press release is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed is to be used for informational purposes only.  Please read all associated full disclosures, disclaimers, and analyst background on our website before investing. Neither Goldman Small Cap Research nor its parent is a registered investment adviser or broker-dealer with FINRA or any other agency. To download this research report or any of our research, view our disclosures and disclaimers, or for more information, visitwww.goldmanresearch.com. GSCR has been compensated $3500 by the company for sponsored research and distribution services. Since 2018, GSCR has been compensated a total of $13,500 by the company for sponsored research services, and a fairness opinion.


Rob Goldman
Managing Director, Research
Goldman Small Cap Research

SOURCE: Goldman Small Cap Research

Zevotek (CE) (USOTC:ZVTK)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Zevotek (CE) Charts.
Zevotek (CE) (USOTC:ZVTK)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Zevotek (CE) Charts.